Infections: News and Research on Bronchiolitis

MeSH tree: C01.748.099.135

GSK sues Pfizer over patents for RSV vaccine

GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.

EU drug watchdog approves first RSV infant, elderly vaccine

Europe's drug watchdog on Friday approved the world's first vaccine for infants and those over 60 against the Respiratory Syncytial Virus, a major cause of hospitalization on the continent, the Amsterdam-based agency said.

FDA approves new drug to protect against RSV in infants

Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.

Using deep learning to identify respiratory disease

A new AI algorithm developed at EPFL and University Hospital Geneva (HUG) will power an intelligent stethoscope called Pneumoscope with the potential to improve the management of respiratory disease in low-resource and remote ...

page 4 from 7